$0.0327
+0 (+0%)
At Close: Aug 27, 2024
Greenlighting Gamida Cell
04:09pm, Tuesday, 27'th Oct 2020
Gamida Cell recently executed a secondary at $4.50 a share on the back of positive Phase 3 clinical data for its lead asset. The cell therapy biotech now trades at half its 2018 post IPO price despite
What Type Of Shareholders Own The Most Number of Gamida Cell Ltd. (NASDAQ:GMDA) Shares?
07:29pm, Tuesday, 18'th Aug 2020
The big shareholder groups in Gamida Cell Ltd. (NASDAQ:GMDA) have power over the company. Large companies usually have...
Gamida Cell to Provide Webcast of Its Annual Meeting of Stockholders
12:00pm, Monday, 17'th Aug 2020
Gamida Cell will webcast its Annual Meeting of Stockholders on Thursday, September 10, 2020, at 10:00 a.m. ET.
Gamida Cell: Q2 Earnings Insights
12:42pm, Tuesday, 11'th Aug 2020
Shares of Gamida Cell (NASDAQ:GMDA) moved higher by 1.6% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 15.91% over the past year to ($0.37)
Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update
12:01pm, Tuesday, 11'th Aug 2020
Gamida Cell reported its financial results for the second quarter of 2020 and provided an update on its clinical programs.
Gamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and Webcast
12:31pm, Tuesday, 04'th Aug 2020
Gamida Cell announced that it will report its second quarter 2020 financial results on Tuesday, August 11, 2020.
Gamida Cell (GMDA) to Report Q2 Earnings: What's in Store?
03:09pm, Thursday, 23'rd Jul 2020
Gamida Cell (GMDA) will provide updates on its pipeline candidates when it releases second-quarter 2020 results.
Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer
12:01pm, Tuesday, 21'st Jul 2020
Gamida Cell announced the appointment of Michele Korfin as chief operating and chief commercial officer.
Has Gamida Cell (GMDA) Outpaced Other Medical Stocks This Year?
03:30pm, Monday, 20'th Jul 2020
Is (GMDA) Outperforming Other Medical Stocks This Year?
Gamida Cell Announces Appointment of David Fox to Its Board of Directors
12:30pm, Tuesday, 07'th Jul 2020
Gamida Cell announced that David Fox has been appointed to its board of directors as an independent member.
Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%
12:58pm, Thursday, 25'th Jun 2020
Ovid Therapeutics (OVID) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Gamida Cell (GMDA) Upgraded to Strong Buy: Here's Why
04:00pm, Friday, 19'th Jun 2020
Gamida Cell (GMDA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum
12:31pm, Friday, 12'th Jun 2020
Gamida Cell will participate in a fireside chat at the JMP Securities Virtual Hematology and Oncology Forum on Thursday, June 18, 2020.
Gamida Cell Ltd. (GMDA): Hedge Funds In Wait-and-See Mode
08:34pm, Wednesday, 10'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Top Ranked Momentum Stocks to Buy for May 28th
02:54pm, Thursday, 28'th May 2020
Top Ranked Momentum Stocks to Buy for May 28th
Sign In
Buy GMDA